AI assistant
Sending…
MEDIFAST INC — Director's Dealing 2022
Mar 21, 2022
33899_dirs_2022-03-21_25fe0508-696f-42ce-9f4a-80d3a4ceed12.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2022-03-16
Reporting Person: Maloney James P. (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-16 | Common Stock | A | 1281 | — | Acquired | 3134 | Direct |
| 2022-03-17 | Common Stock | F | 75 | $180.52 | Disposed | 3059 | Direct |
Footnotes
F1: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock
More from MEDIFAST INC
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 26
Annual Report
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 20
Regulatory Filings
2026
Mar 20